INTERCURE LTD
INCRNASDAQ🏆 #4252 by market capUS Equity
$5.03▼ $0.29 (−5.45%)
Latest quoteTrack INCR
Get earnings, price moves & breaking news on Telegram
24h▼ 5.5%
7d▲ 0.0%
14d▲ 0.0%
30d▼ 11.9%
ytd▲ 39.7%
1y▼ 28.1%
🏦Market Cap
$60M
Small Cap
📈Revenue Growth (YoY)
13.1%
Healthy
📊Gross Margin
10.0%
Thin
💵FCF Margin
4.3%
Moderate
⚖️P/S Ratio
0.8x
Cheap
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $5.03 – $5.03
- 52-Week Range
- $3.40 – $7.55
- Volume (shares)
- 102
- Avg Volume (shares)
- —
- Shares Outstanding
- 11.8M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $270M
- Last Q Revenue
- —
- P/E Ratio
- -3.9
- P/S Ratio
- 0.8x
- EPS (TTM)
- $-3.44
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +15.3%
INTERCURE LTD
INCRFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$270M▲ +13.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
12.3%▼ −3.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$7M▼ −110.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$13M▼ −118.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
10.1M▲ +15.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$137M▼ −$3M YoY
StockOtter · stockotter.spaceAbout INTERCURE LTD
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Jun 2025
Latest News & Updates
News unavailable.